Oxytocin for Weight Loss in Teens

Oxytocin for Weight Loss in Adolescents

Recruiting Phase 2 Interventional Study
Obesity, Adolescent Oxytocin
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
10 – 18
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
55 (estimated)
Sponsor
Massachusetts General Hospital · Other
Who this trial is looking for

This trial is looking for teenagers aged 10 to 18 who are struggling with obesity. Participants will receive either oxytocin or a placebo nasal spray, taken four times a day for 12 weeks, while attending regular study visits and assessments.

Are You a Good Fit for This Trial?
Rules you out Prolonged QT intervalChronic inflammatory bowel diseaseTSH > 2.5 times normal limitALT or AST > 2.5 times normal limitCreatinine > 1.5 mg/dlHyponatremiaType 1 Diabetes MellitusType 2 Diabetes Mellitus if HbA1c > 8%

You may be able to join if

  • I am between 10 and 18 years old.
  • I have obesity.
  • I am willing to maintain my current diet and lifestyle during the study.

You may not be able to join if

  • I have current substance abuse issues.
  • I have lost more than 5 kg in the last 3 months.
  • I follow a nonstandard diet.
  • I have cardiovascular disease.
  • I have epilepsy.
  • I am pregnant or breastfeeding, or I refuse to use contraception.
  • I have an eating disorder.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin in youths with obesity, ages 10-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (1 spray per nostril, 4 times per day) for 12 weeks. Study visits include screening to determine eligibility, 2-part main study visits at baseline, week 8, and week 12, and safety check…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Males and Females, 10-18 years * Obesity (BMI ≥95th percentile for age and gender) * Willingness to maintain current diet and lifestyle for the duration of study participation Exclusion Criteria: * Current substance abuse * Use of prescription or over-the-counter drugs or di…
Contacts

Elizabeth A Lawson, MD, MMSc

617-726-3870

ealawson@partners.org

CONTACT